These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7448355)

  • 1. A lysosomal storage disorder in mice characterized by the accumulation of several sphingolipids.
    Pentchev PG; Gal AE; Boothe AD; Fouks J; Omodeo-Sale F; Brady RO
    Birth Defects Orig Artic Ser; 1980; 16(1):225-30. PubMed ID: 7448355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A lysosomal storage disorder in mice characterized by a dual deficiency of sphingomyelinase and glucocerebrosidase.
    Pentchev PG; Gal AE; Booth AD; Omodeo-Sale F; Fouks J; Neumeyer BA; Quirk JM; Dawson G; Brady RO
    Biochim Biophys Acta; 1980 Sep; 619(3):669-79. PubMed ID: 6257302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingomyelinase activity of livers from control and NCTR-BALB/c mice.
    Bhuvaneswaran C; Morris MD
    IUBMB Life; 1999 Jul; 48(1):105-8. PubMed ID: 10791923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Niemann-Pick C disease: cystine and lipids accumulate in the murine model of this lysosomal cholesterol lipidosis.
    Butler JD; Vanier MT; Pentchev PG
    Biochem Biophys Res Commun; 1993 Oct; 196(1):154-9. PubMed ID: 8216287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysosome lipid storage disorder in NCTR-BALB/c mice: spleen and lung lysosomes store unesterified cholesterol but differ in their phospholipid composition.
    Bhuvaneswaran C; Morris MD
    Mol Cell Biochem; 2000 Nov; 214(1-2):15-22. PubMed ID: 11195785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genetic storage disorder in BALB/C mice with a metabolic block in esterification of exogenous cholesterol.
    Pentchev PG; Boothe AD; Kruth HS; Weintroub H; Stivers J; Brady RO
    J Biol Chem; 1984 May; 259(9):5784-91. PubMed ID: 6325448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of suramin on the activities of degradative enzymes of sphingolipids in rats.
    Constantopoulos G; Rees S; Cragg BG; Barranger JA; Brady RO
    Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):87-97. PubMed ID: 7291729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mice deficient in Neu4 sialidase exhibit abnormal ganglioside catabolism and lysosomal storage.
    Seyrantepe V; Canuel M; Carpentier S; Landry K; Durand S; Liang F; Zeng J; Caqueret A; Gravel RA; Marchesini S; Zwingmann C; Michaud J; Morales CR; Levade T; Pshezhetsky AV
    Hum Mol Genet; 2008 Jun; 17(11):1556-68. PubMed ID: 18270209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysosome lipid storage disorder in NCTR-BALB/c mice. III. Isolation and analysis of storage inclusions from liver.
    Bhuvaneswaran C; Morris MD; Shio H; Fowler S
    Am J Pathol; 1982 Aug; 108(2):160-70. PubMed ID: 6101077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders.
    McGlynn R; Dobrenis K; Walkley SU
    J Comp Neurol; 2004 Dec; 480(4):415-26. PubMed ID: 15558784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sphingolipidoses. Biochemistry and enzymatic mechanisms].
    Gajdos A
    Nouv Presse Med; 1972 Jun; 1(26):1789-92. PubMed ID: 5054020
    [No Abstract]   [Full Text] [Related]  

  • 12. Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis.
    Sango K; McDonald MP; Crawley JN; Mack ML; Tifft CJ; Skop E; Starr CM; Hoffmann A; Sandhoff K; Suzuki K; Proia RL
    Nat Genet; 1996 Nov; 14(3):348-52. PubMed ID: 8896570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of Secondary Ganglioside and Lipid Accumulation in Lysosomal Disease.
    Breiden B; Sandhoff K
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32272755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prosaposin deficiency -- a rarely diagnosed, rapidly progressing, neonatal neurovisceral lipid storage disease. Report of a further patient.
    Elleder M; Jerábková M; Befekadu A; Hrebícek M; Berná L; Ledvinová J; Hůlková H; Rosewich H; Schymik N; Paton BC; Harzer K
    Neuropediatrics; 2005 Jun; 36(3):171-80. PubMed ID: 15944902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of GM2-gangliosidosis with total hexosaminidase deficiency.
    Suzuki Y; Jacob JC; Suzuki K; Suzuki K
    Neurology; 1970 Apr; 20(4):388. PubMed ID: 5535009
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lysosomal diseases in ophthalmology].
    Maione M
    Ann Ottalmol Clin Ocul; 1969 Feb; 95(2):97-100. PubMed ID: 4249546
    [No Abstract]   [Full Text] [Related]  

  • 17. Glycosphingolipid levels in an unusual neurovisceral storage disease characterized by lactosylceramide galactosyl hydrolase deficiency: lactosylceramidosis.
    Dawson G
    J Lipid Res; 1972 Mar; 13(2):207-19. PubMed ID: 5016302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysosome lipid storage disorder in NCTR-BALB/c mice. I. Description of the disease and genetics.
    Morris MD; Bhuvaneswaran C; Shio H; Fowler S
    Am J Pathol; 1982 Aug; 108(2):140-9. PubMed ID: 6765731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary alterations of sphingolipid metabolism in lysosomal storage diseases.
    Prinetti A; Prioni S; Chiricozzi E; Schuchman EH; Chigorno V; Sonnino S
    Neurochem Res; 2011 Sep; 36(9):1654-68. PubMed ID: 21207141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sphingolipidosis].
    Juif JC
    Arch Fr Pediatr; 1971 Nov; 28(9):909-14. PubMed ID: 5144692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.